Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/24/1996 | US5587304 Genetic engineering |
12/24/1996 | US5587302 T cell growth factor |
12/24/1996 | US5587301 DNA encoding a hyaluronan receptor expressed in human umbilical vein endothelial cells |
12/24/1996 | US5587300 Method to increase regulatory molecule production |
12/24/1996 | US5587299 Isolated nucleic acid molecule coding for fibroblast activation protein alpha and uses thereof |
12/24/1996 | US5587289 Isolated nucleic acid molecules which are members of the MAGE-Xp family and uses thereof |
12/24/1996 | US5587287 Thermostable polymerase specific antibody-containing DNA amplification composition and kit |
12/24/1996 | US5587159 Human tissue plasminogen activator |
12/24/1996 | CA1338807C Plasmid vector with pectate lyase signal sequence |
12/21/1996 | CA2169201A1 Lactic bacteria producing exopolysaccharides |
12/19/1996 | WO1996041196A1 Method for detection of antibody to hepatitis c virus second envelope glycoprotein |
12/19/1996 | WO1996041191A1 Methods and uses for apoptin |
12/19/1996 | WO1996041180A1 Anchor libraries and identification of peptide binding sequences |
12/19/1996 | WO1996041178A1 Micelle protection assay |
12/19/1996 | WO1996041170A1 Monospecific antibodies against a subunit of fibrinogen |
12/19/1996 | WO1996041169A1 Functional bioassay for g-protein coupled receptor agonists and antagonists |
12/19/1996 | WO1996041019A1 Use of nucleic acid ligands in flow cytometry |
12/19/1996 | WO1996041018A1 Methods, kits, and compositions for diagnosing papillomavirus infection |
12/19/1996 | WO1996041017A2 Nucleic acid probes and amplification oligonucleotides for neisseria species |
12/19/1996 | WO1996041016A1 Methods for measuring telomere length |
12/19/1996 | WO1996041015A2 Enhancement of alkaline phosphatase with sds in chemiluminescent substrates and enzyme inhibition assays |
12/19/1996 | WO1996041014A1 Thermophilic dna polymerases from thermotoga neapolitana |
12/19/1996 | WO1996041013A1 Method for screening for receptor agonists and antagonists |
12/19/1996 | WO1996041012A1 Universal primer sequence for multiplex dna amplification |
12/19/1996 | WO1996041011A1 Oligonucleotide tags for sorting and identification |
12/19/1996 | WO1996041010A1 Nucleic acid ligands that bind to and inhibit dna polymerases |
12/19/1996 | WO1996041008A1 Methods and compositions for effecting homologous recombination |
12/19/1996 | WO1996041007A1 Male infertility y-deletion detection with multiplex primer combinations |
12/19/1996 | WO1996041000A1 Internal positive controls for nucleic acid amplification |
12/19/1996 | WO1996040999A1 Detection of nucleic acids by formation of template-dependent product |
12/19/1996 | WO1996040998A1 PCR-BASED cDNA SUBTRACTIVE CLONING METHOD |
12/19/1996 | WO1996040992A2 Probe masking method of reducing background in an amplification reaction |
12/19/1996 | WO1996040991A1 Enzyme linked oligonucleotide assays (elonas) |
12/19/1996 | WO1996040989A1 System of probes intended to carry out the typing hla dr, and typing process using said probes |
12/19/1996 | WO1996040987A1 Peptide library and screening method |
12/19/1996 | WO1996040979A1 Methods for evaluation of antimicrobial targets |
12/19/1996 | WO1996040977A1 Origin of replication complex genes |
12/19/1996 | WO1996040974A1 Improved method of expression cloning |
12/19/1996 | WO1996040973A1 Nucleic acid sequences encoding dendroides anti-freeze proteins |
12/19/1996 | WO1996040972A1 Linked linear amplification of nucleic acids |
12/19/1996 | WO1996040971A1 Method of transferring at least two saccharide units with a polyglycosyltransferase |
12/19/1996 | WO1996040968A1 Recombinant production of novel polyketides |
12/19/1996 | WO1996040965A1 Synthetic mammalian chromosome and methods for construction |
12/19/1996 | WO1996040964A2 Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
12/19/1996 | WO1996040963A1 Cationic lipid:dna complexes for gene targeting |
12/19/1996 | WO1996040962A1 Cationic lipid:dna complexes for gene targeting |
12/19/1996 | WO1996040961A1 Peptide-enhanced cationic lipid transfections |
12/19/1996 | WO1996040960A1 A method for promoting enzyme diversity |
12/19/1996 | WO1996040959A1 Cell line producing analgesic compounds for treating pain |
12/19/1996 | WO1996040958A1 Nucleic acid transporters for delivery of nucleic acids into a cell |
12/19/1996 | WO1996040955A1 Adenovirus vectors for gene therapy |
12/19/1996 | WO1996040954A1 Oral delivery of adeno-associated viral vectors |
12/19/1996 | WO1996040953A1 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
12/19/1996 | WO1996040952A1 Plasmid for delivery of nucleic acids to cells and methods of use |
12/19/1996 | WO1996040951A2 Use of ovary-tissue transcriptional factors |
12/19/1996 | WO1996040950A1 Methods and constructs for producing male sterile plants |
12/19/1996 | WO1996040949A1 Induction of male sterility in plants by expression of high levels of avidin |
12/19/1996 | WO1996040948A2 RESISTANCE TO VIRUSES AND VIROIDS IN TRANSGENIC PLANT AND ANIMAL HOSTS EXPRESSING dsRNA-BINDING PROTEIN |
12/19/1996 | WO1996040947A1 Recombinant bacterial system with environmentally limited viability |
12/19/1996 | WO1996040946A1 An autoregulatory tetracycline-regulated system for inducible gene expression in eucaryotes |
12/19/1996 | WO1996040945A2 Nucleic acid respiratory syncytial virus vaccines |
12/19/1996 | WO1996040944A2 Fused soluble mhc heterodimer:peptide complexes and their uses |
12/19/1996 | WO1996040943A1 Use of gram-positive bacteria to express recombinant proteins |
12/19/1996 | WO1996040941A1 Chimeric antibodies for delivery of antigens to selected cells of the immune system |
12/19/1996 | WO1996040940A2 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
12/19/1996 | WO1996040939A2 Expression of functional vertebrate phospholipases in yeast |
12/19/1996 | WO1996040938A1 Chondroitinase production in recombinant proteus vulgaris strains |
12/19/1996 | WO1996040937A2 Adenosine kinase polynucleotides |
12/19/1996 | WO1996040936A1 Hexokinase promoter and assay method |
12/19/1996 | WO1996040935A1 Recombinant hexose oxidase, a method of producing same and use of such enzyme |
12/19/1996 | WO1996040934A1 Process for producing l-lysine |
12/19/1996 | WO1996040933A1 Infectious dengue 2 virus pdk-53 as quadravalent vaccine |
12/19/1996 | WO1996040932A1 Vaccine for porcine reproductive and respiratory syndrome virus |
12/19/1996 | WO1996040931A1 Neutralizing conformational epitopes of chicken anemia virus |
12/19/1996 | WO1996040930A1 Mutants of streptococcal toxin a and methods of use |
12/19/1996 | WO1996040929A2 Transferrin receptor genes |
12/19/1996 | WO1996040928A1 Streptococcal heat shock proteins members of the hsp70 family |
12/19/1996 | WO1996040927A1 Isospora suis vaccine |
12/19/1996 | WO1996040926A2 Detection of cryptosporidium parvum |
12/19/1996 | WO1996040925A2 Regulatory elements conferring tapetum specificity |
12/19/1996 | WO1996040924A2 Cotton fiber transcriptional factors |
12/19/1996 | WO1996040923A1 Macrophage derived chemokine and chemokine analogs |
12/19/1996 | WO1996040922A1 Novel serpin derived from human hypothalamus |
12/19/1996 | WO1996040921A1 Cdr-grafted anti-tissue factor antibodies and methods of use thereof |
12/19/1996 | WO1996040920A1 Modified hemoglobin-like compounds and methods of purifying same |
12/19/1996 | WO1996040919A1 3' utr of the human prohibitin gene |
12/19/1996 | WO1996040918A2 Novel cd40l mutein |
12/19/1996 | WO1996040917A1 NOVEL NuMA-INTERACTING PROTEINS AND METHODS FOR THEIR IDENTIFICATION |
12/19/1996 | WO1996040916A1 Icam-4 materials and methods |
12/19/1996 | WO1996040915A2 Novel ctla4/cd28 ligands and uses therefor |
12/19/1996 | WO1996040914A1 Truncated hepatocyte growth factor variants |
12/19/1996 | WO1996040913A1 A gene encoding a human reduced folate carrier (rfc) and methods for the treatment of methotrexate-resistant, transport-deficient cancer cells |
12/19/1996 | WO1996040912A1 Ob protein compositions and method |
12/19/1996 | WO1996040911A1 Modified steroid hormones for gene therapy and methods for their use |
12/19/1996 | WO1996040910A1 Human growth factors, nucleotide sequence encoding growth factors, and methods of use thereof |
12/19/1996 | WO1996040909A1 Bone stimulating factor |
12/19/1996 | WO1996040908A1 OLIGONUCLEOTIDES SPECIFIC FOR CYTOKINE SIGNAL TRANSDUCER gp130 mRNA |
12/19/1996 | WO1996040907A1 Interleukin-1 receptor intracellular ligand proteins and inhibitors of ligand binding |
12/19/1996 | WO1996040906A1 Optimized minizymes and miniribozymes and uses thereof |
12/19/1996 | WO1996040905A1 Optimized high-yield production of plasmid dna |